17-3930371-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_005173.4(ATP2A3):c.2674G>A(p.Glu892Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00415 in 1,613,738 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0030 ( 4 hom., cov: 31)
Exomes 𝑓: 0.0043 ( 26 hom. )
Consequence
ATP2A3
NM_005173.4 missense
NM_005173.4 missense
Scores
2
8
9
Clinical Significance
Conservation
PhyloP100: 6.17
Genes affected
ATP2A3 (HGNC:813): (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3) This gene encodes one of the SERCA Ca(2+)-ATPases, which are intracellular pumps located in the sarcoplasmic or endoplasmic reticula of muscle cells. This enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen, and is involved in calcium sequestration associated with muscular excitation and contraction. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.021290064).
BP6
Variant 17-3930371-C-T is Benign according to our data. Variant chr17-3930371-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3041510.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP2A3 | NM_005173.4 | c.2674G>A | p.Glu892Lys | missense_variant | 18/21 | ENST00000397041.8 | NP_005164.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP2A3 | ENST00000397041.8 | c.2674G>A | p.Glu892Lys | missense_variant | 18/21 | 1 | NM_005173.4 | ENSP00000380234.3 |
Frequencies
GnomAD3 genomes AF: 0.00300 AC: 457AN: 152250Hom.: 4 Cov.: 31
GnomAD3 genomes
AF:
AC:
457
AN:
152250
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00328 AC: 818AN: 249296Hom.: 0 AF XY: 0.00333 AC XY: 450AN XY: 135134
GnomAD3 exomes
AF:
AC:
818
AN:
249296
Hom.:
AF XY:
AC XY:
450
AN XY:
135134
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00427 AC: 6235AN: 1461370Hom.: 26 Cov.: 33 AF XY: 0.00418 AC XY: 3040AN XY: 726944
GnomAD4 exome
AF:
AC:
6235
AN:
1461370
Hom.:
Cov.:
33
AF XY:
AC XY:
3040
AN XY:
726944
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00300 AC: 457AN: 152368Hom.: 4 Cov.: 31 AF XY: 0.00287 AC XY: 214AN XY: 74508
GnomAD4 genome
AF:
AC:
457
AN:
152368
Hom.:
Cov.:
31
AF XY:
AC XY:
214
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
18
ALSPAC
AF:
AC:
13
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
50
ExAC
AF:
AC:
396
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ATP2A3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 10, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
.;.;.;.;.;D;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
M;M;M;.;M;M;M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;.;N;N;N;.
REVEL
Uncertain
Sift
Benign
T;T;T;.;T;T;T;.
Sift4G
Benign
T;T;T;D;T;T;T;D
Polyphen
B;B;B;.;.;B;P;.
Vest4
MVP
MPC
0.77
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at